1. STAT3 Pathways Contribute to β-HCH Interference with Anticancer Tyrosine Kinase Inhibitors
   Sara Fiorini et al, 2024, International Journal of Molecular Sciences CrossRef
2. Personalizing Therapy Outcomes through Mitogen-Activated Protein Kinase Pathway Inhibition in Non-Small Cell Lung Cancer
   Hasan Alsharoh et al, 2024, Biomedicines CrossRef
3. Precision nanomedicine to treat non-small cell lung cancer
   Akanksha Dessai et al, 2024, Life Sciences CrossRef